Published in Biophys J on November 01, 1998
Distribution of halothane in a dipalmitoylphosphatidylcholine bilayer from molecular dynamics calculations. Biophys J (2000) 1.34
Under the influence of alcohol: the effect of ethanol and methanol on lipid bilayers. Biophys J (2005) 1.32
Computer simulation of small molecule permeation across a lipid bilayer: dependence on bilayer properties and solute volume, size, and cross-sectional area. Biophys J (2004) 1.23
A designed four-alpha-helix bundle that binds the volatile general anesthetic halothane with high affinity. Biophys J (2000) 1.07
Partitioning of anesthetics into a lipid bilayer and their interaction with membrane-bound peptide bundles. Biophys J (2006) 1.03
New insights into the molecular mechanisms of general anaesthetics. Br J Pharmacol (2010) 1.02
Modeling kinetics of subcellular disposition of chemicals. Chem Rev (2009) 0.96
How alcohol chain-length and concentration modulate hydrogen bond formation in a lipid bilayer. Biophys J (2007) 0.92
Membrane structural perturbations caused by anesthetics and nonimmobilizers: a molecular dynamics investigation. Biophys J (2001) 0.92
Interaction between artificial membranes and enflurane, a general volatile anesthetic: DPPC-enflurane interaction. Biophys J (2003) 0.92
Concentration effects of volatile anesthetics on the properties of model membranes: a coarse-grain approach. Biophys J (2004) 0.87
Interaction of anesthetics with open and closed conformations of a potassium channel studied via molecular dynamics and normal mode analysis. Biophys J (2008) 0.85
Molecular dynamics simulations of C2F6 effects on gramicidin A: implications of the mechanisms of general anesthesia. Biophys J (2005) 0.83
Effects of protein binding on a lipid bilayer containing local anesthetic articaine, and the potential of mean force calculation: a molecular dynamics simulation approach. J Mol Model (2013) 0.76
Analysis of pulmonary surfactant by Fourier transform infrared spectroscopy after exposure to sevoflurane and isoflurane. Bosn J Basic Med Sci (2016) 0.75
The cellular membrane as a mediator for small molecule interaction with membrane proteins. Biochim Biophys Acta (2016) 0.75
Sites of alcohol and volatile anaesthetic action on GABA(A) and glycine receptors. Nature (1997) 7.49
Area/lipid of bilayers from NMR. Biophys J (1993) 4.19
Constant pressure and temperature molecular dynamics simulation of a fully hydrated liquid crystal phase dipalmitoylphosphatidylcholine bilayer. Biophys J (1995) 3.41
Do general anaesthetics act by competitive binding to specific receptors? Nature (1984) 3.09
The lateral pressure profile in membranes: a physical mechanism of general anesthesia. Biochemistry (1997) 2.87
What is the surface tension of a lipid bilayer membrane? Biophys J (1996) 2.82
Molecular mechanisms of general anaesthesia. Nature (1982) 2.76
The structure of lipid bilayers and the effects of general anaesthetics. An x-ray and neutron diffraction study. J Mol Biol (1979) 2.67
Molecular interactions between inhaled anesthetics and proteins. Pharmacol Rev (1997) 2.31
The nature of the site of general anesthesia. Int Rev Neurobiol (1985) 2.05
Molecular dynamics investigation of the structure of a fully hydrated gel-phase dipalmitoylphosphatidylcholine bilayer. Biophys J (1996) 2.03
Solute diffusion in lipid bilayer membranes: an atomic level study by molecular dynamics simulation. Biochemistry (1993) 1.78
Binding of halothane to serum albumin demonstrated using tryptophan fluorescence. Anesthesiology (1995) 1.76
Biological membranes behave as non-porous polymeric sheets with respect to the diffusion of non-electrolytes. Nature (1969) 1.69
Different distribution of fluorinated anesthetics and nonanesthetics in model membrane: a 19F NMR study. Biophys J (1997) 1.44
Amphiphilic sites for general anesthetic action? Evidence from 129Xe-[1H] intermolecular nuclear Overhauser effects. Biochim Biophys Acta (1997) 1.41
Contrasting membrane localization and behavior of halogenated cyclobutanes that follow or violate the Meyer-Overton hypothesis of general anesthetic potency. Biophys J (1997) 1.29
Development of monoclonal antibodies for measurement of immunoglobulin G antibody responses in blue and gold macaws (Ara ararauna). Am J Vet Res (1996) 1.24
Mechanisms of general anesthesia. Environ Health Perspect (1990) 1.23
Lipid modulation of nicotinic acetylcholine receptor function: the role of membrane lipid composition and fluidity. Biochim Biophys Acta (1994) 1.12
Distribution of general anesthetics in phospholipid bilayers determined using 2H NMR and 1H-1H NOE spectroscopy. Biochemistry (1995) 1.11
Is membrane expansion relevant to anaesthesia? Nature (1981) 1.11
Pressure reversal of inhalation anesthetic-induced disorder in spin-labeled phospholipid vesicles. Biochim Biophys Acta (1973) 1.08
Differential effects on phospholipid phase transitions produced by structurally related long-chain alcohols. Biochemistry (1979) 1.06
Localization of molecular halothane in phospholipid bilayer model nerve membranes. Anesthesiology (1976) 1.05
Do clinical levels of general anaesthetics affect lipid bilayers? Evidence from Raman scattering. Biochim Biophys Acta (1982) 1.05
Excess chemical potential of small solutes across water--membrane and water--hexane interfaces. J Chem Phys (1996) 1.04
Interactions of anesthetics with the water-hexane interface. A molecular dynamics study. J Phys Chem B (1997) 0.97
Interactions of anesthetics with the membrane-water interface. Chem Phys (1996) 0.94
Does general anesthetic-induced desensitization of the Torpedo acetylcholine receptor correlate with lipid disordering? Mol Pharmacol (1994) 0.89
Nuclear magnetic resonance studies of the interaction of general anesthetics with 1,2-dihexadecyl-sn-glycero-3-phosphorylcholine bilayer. Proc Natl Acad Sci U S A (1976) 0.89
Effects of halothane on dipalmitoylphosphatidylcholine liposomes: a Raman spectroscopic study. Biochemistry (1987) 0.89
Interaction of halothane with lipid bilayers. Mol Pharmacol (1979) 0.88
Fourier transform infrared studies on phospholipid hydration: phosphate-oriented hydrogen bonding and its attenuation by volatile anesthetics. Mol Pharmacol (1987) 0.87
Infrared spectra of phospholipid membranes: interfacial dehydration by volatile anesthetics and phase transition. Biochim Biophys Acta (1990) 0.87
Anesthetics release unfreezable and bound water in partially hydrated phospholipid lamellar systems and elevate phase transition temperature. Mol Pharmacol (1986) 0.86
Inhibitory synapses. Anaesthetics set their sites on ion channels. Nature (1997) 0.86
Molecular orientation of volatile anesthetics at the binding surface: 1H- and 19F-NMR studies of submolecular affinity. Biochim Biophys Acta (1989) 0.86
Molecular dynamics simulation of anesthetic-phospholipid bilayer interactions. J Biomol Struct Dyn (1995) 0.83
The membrane volume occupied by anesthetic molecules: a reinterpretation of the erythrocyte expansion data. Biochim Biophys Acta (1977) 0.83
Implications of two different types of diffusion for biological membranes. Nat New Biol (1971) 0.83
Interactions of the nicotinic acetylcholine receptor transmembrane segments with the lipid bilayer in native receptor-rich membranes. Biochemistry (1997) 0.81
Different subunit requirements for volatile and nonvolatile anesthetics at gamma-aminobutyric acid type A receptors. Mol Pharmacol (1995) 0.78
Association of elevated serum lipid levels with retinal hard exudate in diabetic retinopathy. Early Treatment Diabetic Retinopathy Study (ETDRS) Report 22. Arch Ophthalmol (1996) 3.50
Constant pressure and temperature molecular dynamics simulation of a fully hydrated liquid crystal phase dipalmitoylphosphatidylcholine bilayer. Biophys J (1995) 3.41
Experience with nontreatment of central serous choroidopathy. Arch Ophthalmol (1974) 2.51
Constant-pressure molecular dynamics investigation of cholesterol effects in a dipalmitoylphosphatidylcholine bilayer. Biophys J (1998) 2.15
Molecular dynamics investigation of the structure of a fully hydrated gel-phase dipalmitoylphosphatidylcholine bilayer. Biophys J (1996) 2.03
Central retinal artery occlusion without retrobulbar hemorrhage after retrobulbar anesthesia. Am J Ophthalmol (1982) 2.02
Bietti's crystalline dystrophy. A clinicopathologic correlative study. Arch Ophthalmol (1989) 1.51
The M2 channel of influenza A virus: a molecular dynamics study. FEBS Lett (1998) 1.49
Influence of a knot on the strength of a polymer strand. Nature (1999) 1.38
Dynamical properties of a hydrated lipid bilayer from a multinanosecond molecular dynamics simulation. Biophys J (2001) 1.38
Distribution of halothane in a dipalmitoylphosphatidylcholine bilayer from molecular dynamics calculations. Biophys J (2000) 1.34
Polymorphisms in C2, CFB and C3 are associated with progression to advanced age related macular degeneration associated with visual loss. J Med Genet (2008) 1.31
Follow-up study of detachment of the retinal pigment epithelium. Br J Ophthalmol (1980) 1.30
Exploration of the structural features defining the conduction properties of a synthetic ion channel. Biophys J (1999) 1.27
Disciform degeneration of the macula. II. Pathogenesis. Arch Ophthalmol (1976) 1.26
Molecular dynamics simulation of a synthetic ion channel. Biophys J (1998) 1.26
Ab initio molecular dynamics study of proton transfer in a polyglycine analog of the ion channel gramicidin A. Biophys J (1996) 1.24
Visual function and the subsequent development of exudative age-related macular degeneration. Invest Ophthalmol Vis Sci (1992) 1.20
Natural history of disciform degeneration of the macula. Am J Ophthalmol (1974) 1.20
Abnormal glucose metabolism and parafoveal telangiectasia. Am J Ophthalmol (1986) 1.18
Effects of aspirin on vitreous/preretinal hemorrhage in patients with diabetes mellitus. Early Treatment Diabetic Retinopathy Study report no. 20. Arch Ophthalmol (1995) 1.17
Genome-wide association identifies SKIV2L and MYRIP as protective factors for age-related macular degeneration. Genes Immun (2010) 1.16
Relations between fundus appearance and function. Eyes whose fellow eye has exudative age-related macular degeneration. Invest Ophthalmol Vis Sci (1991) 1.14
Molecular dynamics study of the LS3 voltage-gated ion channel. FEBS Lett (1998) 1.14
Two possible conducting states of the influenza A virus M2 ion channel. FEBS Lett (2000) 1.09
Opsoclonus-myoclonus following the intranasal usage of cocaine. J Neurol Neurosurg Psychiatry (1989) 1.09
Bone and cartilage formation in an experimental model of distraction osteogenesis. J Orthop Trauma (1998) 1.08
A designed four-alpha-helix bundle that binds the volatile general anesthetic halothane with high affinity. Biophys J (2000) 1.07
Structural properties of a highly polyunsaturated lipid bilayer from molecular dynamics simulations. Biophys J (2001) 1.06
A prospective study of xenon arc photocoagulation for central retinal vein occlusion. Br J Ophthalmol (1976) 1.05
Molecular dynamics simulations of a protein on hydrophobic and hydrophilic surfaces. Biophys J (1996) 1.01
X-ray diffraction and computation yield the structure of alkanethiols on gold(111). Science (2008) 1.01
Molecular dynamics simulations of supported phospholipid/alkanethiol bilayers on a gold(111) surface. Biophys J (1999) 1.00
Sensitivities in older eyes with good acuity: cross-sectional norms. Invest Ophthalmol Vis Sci (1987) 0.99
Control of misincorporation of de novo synthesized norleucine into recombinant interleukin-2 in E. coli. Biochem Biophys Res Commun (1988) 0.99
Simulation of the HIV-1 Vpu transmembrane domain as a pentameric bundle. FEBS Lett (1998) 0.99
Xenon arc panretinal photocoagulation for central retinal vein occlusion: a randomised prospective study. Br J Ophthalmol (1979) 0.99
Diet-related macular anomalies in monkeys. Invest Ophthalmol Vis Sci (1980) 0.98
Genetic and phenotypic heterogeneity in pattern dystrophy. Br J Ophthalmol (2005) 0.98
Niacin maculopathy. Ophthalmology (1988) 0.98
Sensitivities in older eyes with good acuity: eyes whose fellow eye has exudative AMD. Invest Ophthalmol Vis Sci (1987) 0.98
Choroidal involvement in systemic necrotizing vasculitis. Arch Ophthalmol (1987) 0.97
Malattia leventinese: refinement of the genetic locus and phenotypic variability in autosomal dominant macular drusen. Am J Ophthalmol (1998) 0.96
Sorsby fundus dystrophy. A family with the Ser181Cys mutation of the tissue inhibitor of metalloproteinases 3. Arch Ophthalmol (1996) 0.94
Purtscher's-like retinopathy in chronic renal failure. Ophthalmology (1992) 0.93
Sorsby fundus dystrophy: reevaluation of variable expressivity in patients carrying a TIMP3 founder mutation. Arch Ophthalmol (1997) 0.93
Results and complications of pneumatic retinopexy. Ophthalmology (1988) 0.93
Discrete expression and distribution pattern of TIMP-3 in the human retina and choroid. Curr Eye Res (1997) 0.92
Membrane structural perturbations caused by anesthetics and nonimmobilizers: a molecular dynamics investigation. Biophys J (2001) 0.92
Natural course of perfused central retinal vein occlusion. Can J Ophthalmol (1995) 0.91
First-principles determination of hybrid bilayer membrane structure by phase-sensitive neutron reflectometry. Biophys J (2000) 0.91
Dynamics of water molecules in the Br(-) solvation shell: an ab initio molecular dynamics study. J Am Chem Soc (2001) 0.91
Epidermolysis bullosa, pyloric atresia, and obstructive uropathy: a report of two case reports with molecular correlation and clinical management. Pediatr Dermatol (2000) 0.91
Hemolytic uremic syndrome associated with Purtscher-like retinopathy. Arch Ophthalmol (1998) 0.90
Short wavelength collective dynamics in phospholipid bilayers: a molecular dynamics study. Phys Rev Lett (2001) 0.90
Fingerprints of amorphous icelike behavior in the vibrational density of states of protein hydration water. Phys Rev Lett (2008) 0.90
Molecular dynamics simulation of four-alpha-helix bundles that bind the anesthetic halothane. FEBS Lett (2000) 0.88
Syphilitic retinitis in a patient with acquired immunodeficiency syndrome-related complex. Am J Ophthalmol (1987) 0.88
Molecular dynamics simulation of a hydrated diphytanol phosphatidylcholine lipid bilayer containing an alpha-helical bundle of four transmembrane domains of the influenza A virus M2 protein. Faraday Discuss (1998) 0.88
A comparison of stereoscopic fluorescein angiography with indocyanine green videoangiography in age-related macular degeneration. Ophthalmology (2000) 0.88
Visual recovery in combined central retinal artery and central retinal vein occlusion. Am J Ophthalmol (1987) 0.86
[Methodology to determine risk zones for sleeping sickness in Côte d'Ivoire by the spatial approach]. Med Trop (Mars) (2001) 0.85
Maculopathy in cynomolgus monkeys. A correlated fluorescein angiographic and ultrastructural study. Arch Ophthalmol (1981) 0.83
Macular degeneration: is aspirin a risk for progressive disease? JAMA (1991) 0.83
Molecular genetic heterogeneity in autosomal dominant drusen. J Med Genet (2001) 0.83
Molecular dynamics simulation of a synthetic four-alpha-helix bundle that binds the anesthetic halothane. FEBS Lett (1999) 0.82
Molecular dynamics simulations of a hydrated protein vectorially oriented on polar and nonpolar soft surfaces. Biophys J (2002) 0.81
Molecular dynamics simulation of Pf1 coat protein. Biophys J (1993) 0.81
Subretinal neovascularization developing after prophylactic argon laser photocoagulation of atrophic macular scars. Am J Ophthalmol (1976) 0.81
Proton transfer drives protein radical formation in Helicobacter pylori catalase but not in Penicillium vitale catalase. J Am Chem Soc (2011) 0.80
[A case of infantile calcifying arteriopathy]. Presse Med (1971) 0.80
Narrow-bore high-performance liquid chromatography of phenylthiocarbamyl amino acids and carboxypeptidase P digestion for protein C-terminal sequence analysis. J Chromatogr (1988) 0.80
[Acute intermittent porphyria at 4 months of age]. Arch Fr Pediatr (1976) 0.79
Influence of highly polyunsaturated lipid acyl chains of biomembranes on the NMR order parameters. J Am Chem Soc (2001) 0.79
Maculopathy associated with combination chemotherapy and osmotic opening of the blood-brain barrier. Am J Ophthalmol (1986) 0.78
A simple protocol for identification of helical and mobile residues in membrane proteins. J Mol Biol (1995) 0.78
Maharishi Vedic vibration technology on chronic disorders and associated quality of life. Front Biosci (2001) 0.77
Follow-up study in eyes with choroidal neovascularization caused by presumed ocular histoplasmosis. Am J Ophthalmol (1977) 0.77
Indirect glutamate neurotoxicity. J Neurotrauma (1998) 0.76
Characterization of an Indonesian isolate of Paecilomyces reniformis. Mycopathologia (2006) 0.76
Clinicopathologic correlation of fluorescein and indocyanine green angiography in exudative age-related macular degeneration. Retina (2000) 0.75
Histoplasmosis-like choroiditis in a nonendemic area: the northwest United States. Retina (1998) 0.75
Argon laser photocoagulation of choroidal neovascular membranes. Int Ophthalmol Clin (1981) 0.75
Towards an understanding of how general anesthetics alter central nervous system protein function. Reg Anesth Pain Med (2001) 0.75
Computer simulation study of synthetic 4-helix bundle that binds halothane. Toxicol Lett (1998) 0.75
Toxic dilatation in Crohn disease with CT correlation. J Comput Assist Tomogr (1985) 0.75
[A case of punctuate epiphyseal dysplasia]. J Radiol Electrol Med Nucl (1972) 0.75
Results of argon laser photocoagulation in presumed ocular histoplasmosis. Am J Ophthalmol (1978) 0.75
[Future of BCG vaccinated children back in contact]. Ann Pediatr (Paris) (1967) 0.75
Lipomas of the mesencephalic tectum and rostral pons associated with sleep apnea syndrome. Clin Neuropathol (1990) 0.75